Literature DB >> 16311107

Recent advances in the basic science of chondrosarcoma.

Richard M Terek1.   

Abstract

Chondrosarcoma are a heterogeneous group of tumors whose treatment is limited to surgical removal. Molecular genetic analysis of these tumors has revealed some of the abnormalities responsible for the traits of the malignant phenotype.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16311107     DOI： 10.1016/j.ocl.2005.09.001

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN： 0030-5898            Impact factor:   2.472


  6 in total

Review 1.  Molecular pathology of chondroid neoplasms: part 2, malignant lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-10-18       Impact factor: 2.199

2.  Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.

Authors:  Lindsey C Wu; Ruth A Kleinerman; Rochelle E Curtis; Sharon A Savage; Amy Berrington de González
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-10       Impact factor: 4.254

Review 3.  Reader's digest of the pathophysiology of bone metastases.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2012-07-14

4.  Chondrosarcoma: with updates on molecular genetics.

Authors:  Mi-Jung Kim; Kyung-Ja Cho; Alberto G Ayala; Jae Y Ro
Journal:  Sarcoma       Date:  2011-02-15

5.  rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.

Authors:  Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Sarah Schetting; Myriam Ekici; Dieter Kohn; Magali Cucchiarini
Journal:  Sarcoma       Date:  2012-05-07

6.  Chondrosarcoma and peroxisome proliferator-activated receptor.

Authors:  K Nishida; T Kunisada; Z N Shen; Y Kadota; K Hashizume; T Ozaki
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.